| Product Code: ETC10186437 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Primary Progressive Multiple Sclerosis Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, 2021 & 2031F |
3.3 China Primary Progressive Multiple Sclerosis Market - Industry Life Cycle |
3.4 China Primary Progressive Multiple Sclerosis Market - Porter's Five Forces |
3.5 China Primary Progressive Multiple Sclerosis Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 China Primary Progressive Multiple Sclerosis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 China Primary Progressive Multiple Sclerosis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 China Primary Progressive Multiple Sclerosis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Primary Progressive Multiple Sclerosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about multiple sclerosis (MS) in China |
4.2.2 Growing healthcare infrastructure and access to advanced treatments |
4.2.3 Rising prevalence of primary progressive MS cases in China |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for MS treatment |
4.3.2 High cost of MS medications and therapies in China |
4.3.3 Lack of reimbursement policies for MS treatments |
5 China Primary Progressive Multiple Sclerosis Market Trends |
6 China Primary Progressive Multiple Sclerosis Market, By Types |
6.1 China Primary Progressive Multiple Sclerosis Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.4 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Immunosuppressants, 2021 - 2031F |
6.1.5 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.1.6 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 China Primary Progressive Multiple Sclerosis Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Disease-Modifying Therapy, 2021 - 2031F |
6.2.3 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.2.4 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Rehabilitation, 2021 - 2031F |
6.2.5 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 China Primary Progressive Multiple Sclerosis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.3 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.4 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Injection, 2021 - 2031F |
6.3.5 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 China Primary Progressive Multiple Sclerosis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 China Primary Progressive Multiple Sclerosis Market Revenues & Volume, By Others, 2021 - 2031F |
7 China Primary Progressive Multiple Sclerosis Market Import-Export Trade Statistics |
7.1 China Primary Progressive Multiple Sclerosis Market Export to Major Countries |
7.2 China Primary Progressive Multiple Sclerosis Market Imports from Major Countries |
8 China Primary Progressive Multiple Sclerosis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of primary progressive MS |
8.2 Number of clinical trials for new MS treatments in China |
8.3 Patient adherence rate to prescribed MS treatment plans |
8.4 Rate of adoption of advanced MS treatment technologies in Chinese healthcare facilities |
8.5 Number of MS patient support groups and advocacy organizations in China |
9 China Primary Progressive Multiple Sclerosis Market - Opportunity Assessment |
9.1 China Primary Progressive Multiple Sclerosis Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 China Primary Progressive Multiple Sclerosis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 China Primary Progressive Multiple Sclerosis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 China Primary Progressive Multiple Sclerosis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Primary Progressive Multiple Sclerosis Market - Competitive Landscape |
10.1 China Primary Progressive Multiple Sclerosis Market Revenue Share, By Companies, 2024 |
10.2 China Primary Progressive Multiple Sclerosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here